
    
      This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed
      to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel at
      Weeks 2, 4, 8, and 12. To be eligible for the study subjects must be at least 9 years of age
      and have a clinical diagnosis of moderate to severe acne
    
  